3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Head and Neck Neoplasms
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Cisplatin
32
Radiotherapy, Intensity-Modulated
21
Magnetic Resonance Spectroscopy
21
Radiotherapy
16
Specimen Handling
15
Radiation
14
Carboplatin
14
pembrolizumab
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Paclitaxel
8
Chemoradiotherapy
7
Biopsy
7
Taxes
6
Surveys and Questionnaires
6
Cetuximab
6
Nivolumab
5
Surgical Procedures, Operative
4
Observation
4
Fluorodeoxyglucose F18
4
Drug Therapy
4
Docetaxel
4
durvalumab
3
(225)Ac-DOTA-c(RGDyK)
3
toripalimab
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Nimorazole
×
1 year
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled